137 related articles for article (PubMed ID: 2483738)
1. [Prostaglandin interaction in the human liver].
Virgolini I; Weiss K; Hermann M; Müller C; Sinzinger H
Klin Wochenschr; 1989 Dec; 67(24):1229-35. PubMed ID: 2483738
[TBL] [Abstract][Full Text] [Related]
2. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor.
Virgolini I; Li S; Sillaber C; Majdic O; Sinzinger H; Lechner K; Bettelheim P; Valent P
J Biol Chem; 1992 Jun; 267(18):12700-8. PubMed ID: 1377673
[TBL] [Abstract][Full Text] [Related]
3. Characterization of prostaglandin and thromboxane receptors expressed on a megakaryoblastic leukemia cell line, MEG-01s.
Watanabe T; Yatomi Y; Sunaga S; Miki I; Ishii A; Nakao A; Higashihara M; Seyama Y; Ogura M; Saito H
Blood; 1991 Nov; 78(9):2328-36. PubMed ID: 1718495
[TBL] [Abstract][Full Text] [Related]
4. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin moieties that determine receptor binding specificity in the bovine corpus luteum.
Anderson LE; Schultz MK; Wiltbank MC
J Reprod Fertil; 1999 May; 116(1):133-41. PubMed ID: 10505064
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prostaglandin-receptors in human and rat liver: interspecies differences at the prostaglandin receptor-level.
Virgolini I; Müller C; Hermann M; Schütz W; Sinzinger H
Prostaglandins; 1988 Dec; 36(6):807-18. PubMed ID: 2469102
[TBL] [Abstract][Full Text] [Related]
7. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
Ashby B
Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
[TBL] [Abstract][Full Text] [Related]
8. Human hepatocellular cancers show decreased prostaglandin E1 binding capacity.
Virgolini I; Sinzinger H; Müller C; Hermann M
Br J Cancer; 1989 Mar; 59(3):407-9. PubMed ID: 2539179
[TBL] [Abstract][Full Text] [Related]
9. Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease.
Li SR; Yang Q; Koller E; Kurtaran A; Bischof C; Leimer M; Rauscha F; Pidlich J; Virgolini I
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2066-73. PubMed ID: 9351373
[TBL] [Abstract][Full Text] [Related]
10. Acetylsalicylic acid (ASA) protects the prostaglandin-cAMP-system of human hypernephroma cells against irradiation-induced alterations.
Li SR; Yang Q; Wandl E; Pirker W; Virgolini I
Br J Cancer; 1993 Oct; 68(4):695-701. PubMed ID: 7691143
[TBL] [Abstract][Full Text] [Related]
11. [3H]iloprost and prostaglandin E2 compete for the same receptor site on cardiac sarcolemmal membranes.
Lerner RW; Lopaschuk GD; Catena RC; Olley PM
Biochim Biophys Acta; 1992 Apr; 1105(2):189-92. PubMed ID: 1375098
[TBL] [Abstract][Full Text] [Related]
12. Affinity for [3H]iloprost binding sites and cAMP synthesis activity of a 3-oxa-methano prostaglandin I1 analog, SM-10906, in human platelets and endothelial cells.
Hiroi T; Maruyama K; Hattori K; Ohnuki T; Nagatomo T; Watanabe K; Yamamoto T; Hara Y
Jpn J Pharmacol; 1997 May; 74(1):37-43. PubMed ID: 9195295
[TBL] [Abstract][Full Text] [Related]
13. Separate receptors for prostacyclin and prostaglandin E2 on human gel-filtered platelets.
Eggerman TL; Andersen NH; Robertson RP
J Pharmacol Exp Ther; 1986 Mar; 236(3):568-73. PubMed ID: 2869139
[TBL] [Abstract][Full Text] [Related]
14. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 binding sites in human renal tissue: characterization and localization by radioligand binding and autoradiography.
Eriksson LO; Larsson B; Hedlund H; Andersson KE
Acta Physiol Scand; 1990 Jul; 139(3):393-404. PubMed ID: 2173350
[TBL] [Abstract][Full Text] [Related]
16. Interrelationships between PGE1 and PGI2 binding and stimulation of adenylate cyclase.
Garrity MJ; Westcott KR; Eggerman TL; Andersen NH; Storm DR; Robertson RP
Am J Physiol; 1983 Apr; 244(4):E367-72. PubMed ID: 6132556
[TBL] [Abstract][Full Text] [Related]
17. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
Kiriyama M; Ushikubi F; Kobayashi T; Hirata M; Sugimoto Y; Narumiya S
Br J Pharmacol; 1997 Sep; 122(2):217-24. PubMed ID: 9313928
[TBL] [Abstract][Full Text] [Related]
18. Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques.
Sharif NA; Davis TL
J Pharm Pharmacol; 2002 Apr; 54(4):539-47. PubMed ID: 11999132
[TBL] [Abstract][Full Text] [Related]
19. Enrichment and characterization of specific [3H]PGE2 binding sites in the porcine gastric mucosa.
Beinborn M; Netz S; Staar U; Sewing KF
Eur J Pharmacol; 1988 Mar; 147(2):217-26. PubMed ID: 2452750
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data.
Sharif NA; Xu SX; Williams GW; Crider JY; Griffin BW; Davis TL
J Pharmacol Exp Ther; 1998 Aug; 286(2):1094-102. PubMed ID: 9694973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
